A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity.
Vasse M, Zuber B, Goubeau L, Ballester MC, Roumier M, Delcominette F, Habarou F, Jolly E, Ackermann F, Cerf C, Farfour E, Pascreau T; SARS-CoV-2 Foch Hospital Study Group.
Vasse M, et al. Among authors: jolly e.
Clin Chem Lab Med. 2021 Feb 22;59(7):1315-1322. doi: 10.1515/cclm-2020-1801. Print 2021 Jun 25.
Clin Chem Lab Med. 2021.
PMID: 33606928
Free article.